Sinopep-Allsino Bio Pharmaceutical ,Ltd. PEG Ratio

The latest PEG ratio for 688076.SS is -85.9. That is below the Healthcare sector average of 11.77. Investors often review this figure alongside Sinopep-Allsino Bio Pharmaceutical ,Ltd.'s historical trend and sector peers before judging valuation or financial health.

Against Healthcare companies, 688076.SS currently prints -85.9 for PEG ratio, while the sector average sits near 11.77. That is roughly 829.7% below the sector mean. Large gaps often invite a closer look at Sinopep-Allsino Bio Pharmaceutical ,Ltd.'s growth, margins, and balance sheet.

A PEG ratio of -85.9 for Sinopep-Allsino Bio Pharmaceutical ,Ltd. is not 'good' or 'bad' on its own. Compare it with the peer average (11.77) and with 688076.SS's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.

After noting 688076.SS's PEG ratio (-85.9), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Sinopep-Allsino Bio Pharmaceutical ,Ltd.'s PEG ratio against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.